Dr. Agrawals Eye Hospital Fair Value
Dr. Agrawals Eye Hospital (DRAGARWQ) average fair value is ₹3046.27 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹5091.9 (-40.17%), fair value range ₹633.18–₹8074.51. Also explore DRAGARWQ price movement history to track price trends across different timeframes.
Fair Value Analysis Export
DRAGARWQ Fair Value vs Current Price — Valuation Summary
DRAGARWQ average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). See DRAGARWQ book value comparison to compare market price against book value per share.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
DRAGARWQ Fair Value Analysis — Data Sources & Coverage
Dr. Agrawals Eye Hospital financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit Dr. Agrawals Eye Hospital share price screener.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
DRAGARWQ vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Dr. Agrawals Eye Hospital P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| One Global Service Provi… | ONEGLOBAL | 14.84 | 9.12 | ₹920 |
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Gujarat Kidney and Super… | GKSL | 83.28 | 3.9 | ₹1,117 |
| Invicta Diagnostic | INVICTA | 17.24 | 1.68 | ₹80 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.